VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Pulse/Companies/Compare
Colossal Biosciences
VS
Flare Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

CB
Colossal Biosciences

Colossal Biosciences is a genetic engineering company working to de-extinct species like the woolly mammoth and dire wolf while commercializing spinout biotech applications.

2 Pulse stories
FT
Flare Therapeutics

Flare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcription factors, including a first-in-class ARON-targeting degrader for prostate cancer.

2 Pulse stories
Total Raised
$850M
$290M
Colossal BiosciencesFlare Therapeutics
Last Valuation
$10.3B
Colossal BiosciencesFlare Therapeutics
Biotech
Sector
Biotech
2021
Founded
2021
Dallas, Texas
HQ
Cambridge, Massachusetts
Private
Status
Private
Colossal Biosciences investors
TWG GlobalThomas TullMark WalterTim DraperWinklevoss CapitalIn-Q-TelARCH Venture PartnersTom Brady
Flare Therapeutics investors
Third Rock VenturesNextech InvestPfizer VenturesBoxer CapitalGordonMD Global InvestmentsInvusCasdin CapitalEli Lilly and Company

Data from Value Add Pulse coverage and company research — see the full threads for Colossal Biosciences and Flare Therapeutics.

@Trace_Cohen·t@nyvp.com